ANXA2R and prostate carcinoma: Mechanisms specific to cancer dormancy in the bone endosteal niche have been described in the context of prostate cancer, for which the binding of annexin II receptor expressing prostate cancer cells to osteoblasts promotes the expression and secretion of growth arrest-specific 6 (GAS6).